A randomized phase II study comparing capecitabine alone with capecitabine and oral cyclophosphamide in patients with advanced breast cancer-cyclox II

Capecitabine and cyclophosphamide are active in patients with advanced breast cancer, have non-overlapping toxic effects and synergy pre-clinically. We explored the efficacy and toxic effect of an all-oral combination of capecitabine with cyclophosphamide versus capecitabine alone in a multicentre,...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Annals of oncology 2013-07, Vol.24 (7), p.1828
Hauptverfasser:	Harvey, V J, Sharples, K J, Isaacs, R J, Jameson, M B, Jeffery, G M, McLaren, B R, Pollard, S, Riley, G A, Simpson, A B, Hinder, V A, Scott, J N, Dzhelali, M V, Findlay, M P
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!